X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4625) 4625
Publication (411) 411
Newsletter (316) 316
Newspaper Article (274) 274
Book Review (86) 86
Magazine Article (50) 50
Transcript (28) 28
Book Chapter (25) 25
Trade Publication Article (13) 13
Conference Proceeding (9) 9
Book / eBook (8) 8
Dissertation (4) 4
Data Set (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3338) 3338
atrial fibrillation (3296) 3296
index medicus (2716) 2716
male (1818) 1818
female (1814) 1814
aged (1648) 1648
cardiac & cardiovascular systems (1535) 1535
stroke (1455) 1455
middle aged (1301) 1301
risk factors (1171) 1171
atrial-fibrillation (1140) 1140
cardiac arrhythmia (941) 941
warfarin (935) 935
anticoagulants (832) 832
mortality (792) 792
atrial fibrillation - drug therapy (781) 781
aged, 80 and over (769) 769
anticoagulants - therapeutic use (729) 729
prevention (723) 723
treatment outcome (648) 648
management (647) 647
atrial fibrillation - complications (601) 601
care and treatment (595) 595
analysis (594) 594
risk (590) 590
stroke - prevention & control (579) 579
adult (572) 572
prevalence (538) 538
cost-benefit analysis (527) 527
heart (526) 526
cardiology (522) 522
heart failure (512) 512
research (508) 508
atrial fibrillation - epidemiology (506) 506
medicine, general & internal (493) 493
patients (481) 481
retrospective studies (457) 457
cardiovascular (450) 450
atrial fibrillation - economics (440) 440
fibrillation (430) 430
atrial fibrillation - therapy (425) 425
pharmacology & pharmacy (416) 416
medical research (413) 413
therapy (404) 404
dabigatran (396) 396
atrial fibrillation - diagnosis (394) 394
medicine & public health (394) 394
abridged index medicus (391) 391
stroke prevention (388) 388
warfarin - therapeutic use (374) 374
medicine, experimental (367) 367
risk-factors (363) 363
drug therapy (362) 362
stroke - etiology (360) 360
anticoagulation (354) 354
hypertension (350) 350
time factors (347) 347
cardiovascular disease (345) 345
cardiovascular diseases (345) 345
health aspects (344) 344
epidemiology (337) 337
anticoagulants - economics (329) 329
electrocardiography (328) 328
population (328) 328
cost-effectiveness (324) 324
incidence (324) 324
peripheral vascular disease (323) 323
prospective studies (320) 320
studies (316) 316
anticoagulants - administration & dosage (315) 315
risk assessment (306) 306
atrial fibrillation - physiopathology (300) 300
catheter ablation (294) 294
comorbidity (283) 283
ablation (281) 281
anticoagulants - adverse effects (280) 280
internal medicine (271) 271
surgery (271) 271
follow-up studies (268) 268
anti-arrhythmia agents - therapeutic use (266) 266
administration, oral (264) 264
arrhythmia (264) 264
outcomes (264) 264
usage (256) 256
quality of life (254) 254
cardiac patients (252) 252
medicine (244) 244
thromboembolism (244) 244
rivaroxaban (242) 242
clinical trials (238) 238
health care sciences & services (236) 236
prognosis (235) 235
metaanalysis (229) 229
cohort studies (223) 223
stroke - epidemiology (223) 223
hospitals (222) 222
diagnosis (214) 214
guidelines (214) 214
atrial fibrillation - surgery (206) 206
warfarin - economics (206) 206
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5209) 5209
German (32) 32
Spanish (32) 32
French (22) 22
Portuguese (19) 19
Italian (8) 8
Japanese (8) 8
Russian (8) 8
Polish (3) 3
Swedish (3) 3
Chinese (2) 2
Czech (2) 2
Hebrew (2) 2
Hungarian (2) 2
Turkish (2) 2
Danish (1) 1
Korean (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 04/2014, Volume 129, Issue 15, pp. 1568 - 1576
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 11, pp. 1075 - 1082.e1
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 189, pp. 40 - 47
Journal Article
Circulation, ISSN 0009-7322, 2017, Volume 136, Issue 19, pp. 1784 - 1794
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2014, Volume 111, Issue 6, pp. 1167 - 1176
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 06/2014, Volume 129, Issue 23, pp. 2371 - 2379
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 05/2015, Volume 131, Issue 21, pp. 1843 - 1850
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2005, Volume 149, Issue 4, pp. 657 - 663
Journal Article
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 2011, Volume 154, Issue 1, pp. 1 - 11
Background: Warfarin reduces the risk for ischemic stroke in patients with atrial fibrillation (AF) but increases the risk for hemorrhage. Dabigatran is a... 
POPULATION | MEDICINE, GENERAL & INTERNAL | THERAPY | MANAGEMENT | RISK-FACTOR | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | HEMORRHAGIC COMPLICATIONS | CLINICAL CLASSIFICATION SCHEMES | NATIONAL REGISTRY | ASPIRIN | Myocardial Infarction - chemically induced | Markov Chains | Anticoagulants - administration & dosage | Humans | Anticoagulants - economics | Warfarin - adverse effects | Warfarin - economics | Benzimidazoles - economics | Dabigatran | Warfarin - administration & dosage | Fibrinolytic Agents - adverse effects | Ischemic Attack, Transient - prevention & control | Benzimidazoles - administration & dosage | beta-Alanine - economics | Sensitivity and Specificity | Aged, 80 and over | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Quality-Adjusted Life Years | Stroke - prevention & control | beta-Alanine - adverse effects | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Fibrinolytic Agents - economics | Cost-Benefit Analysis | Intracranial Hemorrhages - chemically induced | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Stroke (Disease) | Prevention | Complications and side effects | Warfarin | Atrial fibrillation | Dosage and administration | Research | Drug therapy | Risk factors
Journal Article
Stroke, ISSN 0039-2499, 06/2013, Volume 44, Issue 6, pp. 1676 - 1681
Background and Purpose-To estimate the cost-effectiveness of stroke prevention in patients with nonvalvular atrial fibrillation by using novel oral... 
Intracranial hemorrhage | Stroke | Anticoagulation | Markov model | Cost-effectiveness | Atrial fibrillation | cost-effectiveness | ANTICOAGULATION CONTROL | QUALITY | anticoagulation | stroke | ASPIRIN | CLINICAL NEUROLOGY | PROPHYLAXIS | atrial fibrillation | HEART-DISEASE | BENEFIT | THERAPY | intracranial hemorrhage | SCORES | PERIPHERAL VASCULAR DISEASE | UPDATE | UTILITY | Thiophenes - therapeutic use | Markov Chains | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | United States | Humans | Anticoagulants - economics | Thiophenes - administration & dosage | Warfarin - economics | Benzimidazoles - economics | Dabigatran | Morpholines - economics | Warfarin - administration & dosage | Warfarin - therapeutic use | Dose-Response Relationship, Drug | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - economics | Stroke - epidemiology | Thiophenes - economics | Pyridones - economics | beta-Alanine - analogs & derivatives | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Quality-Adjusted Life Years | Stroke - prevention & control | Administration, Oral | Morpholines - administration & dosage | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - administration & dosage | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Models, Statistical | Pyrazoles - economics | Pyrazoles - administration & dosage | Cost-Benefit Analysis | Aged | Pyridones - therapeutic use | Cohort Studies
Journal Article